These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1159815)

  • 41. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.
    Earl RA; Townsend LB
    J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Down regulation of Qa gene expression on drug-modified tumor cells.
    Leroy E; Lattuada D; Casnici C; Franco P; Marelli OE
    Tumori; 1993 Dec; 79(6):439-43. PubMed ID: 8171747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells.
    Campanile F; Iorio AM; Bonmassar E
    Int J Immunopharmacol; 1984; 6(4):251-8. PubMed ID: 6480192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug.
    Bonmassar E; Bonmassar A; Vadlamudi S; Goldin A
    Proc Natl Acad Sci U S A; 1970 Aug; 66(4):1089-95. PubMed ID: 5273445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated mice.
    Riccardi C; Fioretti MC; Giampietri A; Puccetti P; Goldin A; Bonmassar E
    J Natl Cancer Inst; 1978 May; 60(5):1083-90. PubMed ID: 642028
    [No Abstract]   [Full Text] [Related]  

  • 46. Con A agglutination of DTIC-altered lymphoma cells.
    Nicolotti G; Gelfi P; Marelli O; Nicolin A
    Pharmacol Res Commun; 1978 Apr; 10(4):313-24. PubMed ID: 684037
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Mizuno NS; Decker RW; Zakis B
    Biochem Pharmacol; 1975 Mar; 24(5):615-9. PubMed ID: 1168474
    [No Abstract]   [Full Text] [Related]  

  • 48. Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide.
    Ballerini P; Franchi A; Fuschiotti P; Piccioni D; Bonmassar E
    Cancer Chemother Pharmacol; 1989; 24(6):359-62. PubMed ID: 2791188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-cell lymphoma induction by radiation leukemia virus in athymic nude mice.
    Ricciardi-Castagnoli P; Lieberman M; Finn O; Kaplan HS
    J Exp Med; 1978 Nov; 148(5):1292-310. PubMed ID: 214507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of new antigenic properties on DTIC-treated L1210 clones.
    Marelli O; Franco P; Canti G; Prandoni N; Ricci L
    Tumori; 1988 Aug; 74(4):387-92. PubMed ID: 3263723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of cobalt-60 gamma rays and DTIC (5-(3,3 dimethyl-1-triazeno)-imidazole-r-carboxamide) on human malignant melanomas grown in athymic nude mice.
    Rofstad EK; Brustad T; Johannessen JV; Mossige J
    Br J Radiol; 1977 May; 50(593):314-20. PubMed ID: 861450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo.
    Fioretti MC; Romani L; Bonmassar A; Taramelli D
    J Immunopharmacol; 1980; 2(2):189-212. PubMed ID: 6821551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.
    Fuschiotti P; Fioretti MC; Romani L; Puccetti P
    Cancer Immunol Immunother; 1989; 29(2):139-43. PubMed ID: 2470506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunological cross-reactivity between H-2Dk product and DTIC-treated H-2d lymphoma.
    Marelli O; Testorelli C; Canti G; Festenstein H; Nicolin A
    J Immunogenet; 1982 Dec; 9(6):407-12. PubMed ID: 6186748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA methylating activity in murine lymphoma cells treated with xenogenizing chemicals.
    Puccetti P; Allegrucci M; Borri Voltattorni C; Romani L; Dominici P; Fioretti MC
    Cancer Detect Prev Suppl; 1987; 1():311-6. PubMed ID: 2446756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Humoral immune responses to human lymphoma cell heterotransplants in the central nervous system of athymic, nude mice.
    Adelman DC; Miller RA; Kaplan HS
    Int J Cancer; 1980 Apr; 25(4):467-73. PubMed ID: 6989764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids.
    Dillehay DL; Shealy YF; Lamon EW
    Cancer Res; 1989 Jan; 49(1):44-50. PubMed ID: 2783245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice.
    Campanile F; Crino L; Bonmassar E; Houchens D; Goldin A
    Cancer Res; 1977 Feb; 37(2):394-8. PubMed ID: 832264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.
    Asjö B; Skoog L; Palminger I; Wiener F; Isaak D; Cerny J; Fenyö EM
    Cancer Res; 1985 Mar; 45(3):1040-5. PubMed ID: 3871660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.